News

04/18/2019 - 13:42
Article

Novel antibiotics: DEINOVE signs an agreement with the Institut Pasteur (Pasteur MS Carnot Institute) to explore the potential of new targeted strains

DEINOVE, a French biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics and nutrition, has announced that it will benefit from the Institut Pasteur's provision of biological resources for the research of new antimicrobial agents from original strains. The Institut Pasteur (Pasteur MS Carnot Institute), one of the most renowned worldwide players in the area of infectious disease research, will entrust a targeted selection of strains from their bacterial collection to DEINOVE.